Difference between revisions of "Category:Malignant solid neoplasm, ERBB2-mutated medications"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
m
 

Latest revision as of 21:07, 21 September 2023

Medications with some degree of efficacy in the treatment of HER2+ tumors, regardless of anatomic site of origin.

Pages in category "Malignant solid neoplasm, ERBB2-mutated medications"

The following 5 pages are in this category, out of 5 total.